Certara Awarded European Medicines Agency Project to Assess Real-World Data Landscape for CAR-T Cell Therapies
Project will evaluate content, quality, and accessiblity of available real-world data sources for six CAR-T cell therapies currently approved for use in the European Union (EU) Radnor, PA – 2025年1月22日 – Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ(Nasdaq:CERT) はCERT), a global leader in model-informed drug development, announced the award of a European Medicines Agency (EMA) project to … Continued